Invasive Intervention of Local Complications of Acute Pancreatitis
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Sep 4, 2023
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding the best ways to treat local complications that can arise from acute pancreatitis, which is a sudden inflammation of the pancreas. The study will specifically look at different strategies for draining fluid and removing infected tissue that may develop due to this condition. Researchers want to gather real-world data to understand how effective and safe these treatments are, especially regarding when and how they are done. This is important because current information comes from very specific patient groups, and it's unclear if those results apply to everyone.
To participate in this study, individuals must be diagnosed with acute pancreatitis and have localized complications confirmed by imaging tests, such as scans. They must also be willing to take part in the study and sign a consent form. On the other hand, if a participant improves with non-invasive (conservative) treatments and does not need any invasive procedures during their hospital stay, they will not be eligible for this trial. Participants can expect to be part of a study that aims to improve treatment approaches for future patients with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admission diagnosis of acute pancreatitis;
- • Localized complications confirmed by imaging examinations;
- • Voluntary participation in the study and signing of an informed consent form.
- Exclusion Criteria:
- • Improved with conservative treatment without invasive interventions for local complications during hospitalization.
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Beijing, Beijing, China
Patients applied
Trial Officials
Dong Wu
Principal Investigator
Peking Union Medical College Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported